In SMC1A-mutated CdLS cell lines, this increased oxidative stress has been associated with genomic instability, and it has been shown to be partially rescued by antioxidant drug treatment, raising the question whether this treatment could ameliorate some clinical features recurrent in CdLS patients (Cukrov et al., 2018). This evidence concerns the gene SMC1A and Cornelia de Lange syndrome.